Intra-Cellular Therapies Inc (ITCI)
131.81
+0.06
(+0.05%)
USD |
NASDAQ |
Mar 28, 16:00
131.81
0.00 (0.00%)
After-Hours: 20:00
Intra-Cellular Therapies Free Cash Flow: -73.50M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 18.06B |
| Moderna Inc | -4.055B |
| Eli Lilly and Co | 414.30M |
| AbbVie Inc | 17.83B |
| Sage Therapeutics Inc | -267.19M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.08M |
| Cash from Investing (Quarterly) | -149.89M |
| Cash from Financing (Quarterly) | 5.606M |
| Free Cash Flow Per Share (Quarterly) | -0.1192 |
| Free Cash Flow to Equity (Quarterly) | -12.65M |
| Free Cash Flow to Firm (Quarterly) | -12.65M |
| Free Cash Flow Yield | -0.54% |